Last $30.38 USD
Change Today +0.63 / 2.12%
Volume 313.1K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ron Cohen M.D.

Founder, Chief Executive Officer, President and Director, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 126 board members in 3 different organizations across 3 different industries.

See Board Relationships
58$3,918,022
As of Fiscal Year 2013

Background*

Dr. Ron Cohen, M.D., is the Founder of Acorda Therapeutics, Inc. and has been its Chief Executive Officer and President since 1995. Dr. Cohen served as Principal in the startup of Advanced Tissue Sciences, Inc. He served as the Chairman Emeritus of the New York Biotechnology Association and served as its Chairman and Director. Dr. Cohen serves as the Chairman of Emerging Company Section at the Biotechnology Industry Organization (BIO). He served as the Chairman of Acorda ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

Former Director
Chairman of Emerging Companies Section and Director
1995-Present
Founder, Chief Executive Officer, President and Director
2011-Present
Director and Member of Compensation Committee

Education*

BA
Princeton University
MD
Edward S. Harkness Eye Institute

Other Affiliations*

Annual Compensation*

Salary$720,833
Total Annual Compensation$720,833

Stock Options*

Restricted Stock Awards$685,350
All Other Compensation$7,650
Exercised Options289,778
Exercised Options Value$9,242,341
Exercisable Options754,449
Unexercisable Options230,809
Total Value of Options$9,242,341
Total Number of Options1,275,036

Total Compensation*

Total Annual Cash Compensation$1,256,283
Total Short Term Compensation$720,833
Other Long Term Compensation$693,000
Total Calculated Compensation$3,918,022
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $30.38 USD +0.63

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.